Bioxytran Inc
(BIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,236 | -574 | -4,563 | -3,394 | -2,266 |
| Depreciation Amortization | 34 | 2 | 357 | 353 | 351 |
| Other Working Capital | 492 | -2 | 3,202 | 2,057 | 1,548 |
| Other Operating Activity | 530 | 464 | 229 | 301 | 26 |
| Operating Cash Flow | $-180 | $-110 | $-775 | $-683 | $-340 |
| Cash Flows From Investing Activities | |||||
| Purchase Sale Intangibles | -5 | -6 | -44 | -38 | -25 |
| Other Investing Activity | -5 | -6 | -44 | -38 | -25 |
| Investing Cash Flow | $-5 | $-6 | $-44 | $-38 | $-25 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 110 | 100 | N/A | N/A | 0 |
| Common Stock Issued | 63 | N/A | 550 | 505 | 115 |
| Financing Cash Flow | $173 | $100 | $550 | $505 | $115 |
| Beginning Cash Position | 26 | 26 | 295 | 295 | 295 |
| End Cash Position | 14 | 10 | 26 | 80 | 45 |
| Net Cash Flow | $-13 | $-16 | $-269 | $-215 | $-250 |
| Free Cash Flow | |||||
| Operating Cash Flow | -180 | -110 | -775 | -683 | -340 |
| Free Cash Flow | -180 | -110 | -775 | -683 | -340 |